145 related articles for article (PubMed ID: 12025965)
1. Preliminary mutational analysis of the human kinin B2 receptor for nonpeptide antagonist ligands recognition.
Meini S; Cucchi P; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Can J Physiol Pharmacol; 2002 Apr; 80(4):303-9. PubMed ID: 12025965
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
[TBL] [Abstract][Full Text] [Related]
3. A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.
Bellucci F; Meini S; Cucchi P; Catalani C; Reichert W; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Br J Pharmacol; 2003 Oct; 140(3):500-6. PubMed ID: 12970081
[TBL] [Abstract][Full Text] [Related]
4. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
5. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
6. Identification of a key region of kinin B(1) receptor for high affinity binding of peptide antagonists.
Bastian S; Pruneau D; Loillier B; Robert C; Bonnafous JC; Paquet JL
J Biol Chem; 2000 Mar; 275(9):6107-13. PubMed ID: 10692400
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide antagonists for kinin receptors.
Altamura M; Meini S; Quartara L; Maggi CA
Regul Pept; 1999 Mar; 80(1-2):13-26. PubMed ID: 10235630
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of bradykinin receptors in Chinese hamster ovary cells stably expressing the human B2 bradykinin receptor.
Zhang SP; Wang HY; Lovenberg TW; Codd EE
Int Immunopharmacol; 2001 May; 1(5):955-65. PubMed ID: 11379050
[TBL] [Abstract][Full Text] [Related]
11. Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways.
Austin CE; Faussner A; Robinson HE; Chakravarty S; Kyle DJ; Bathon JM; Proud D
J Biol Chem; 1997 Apr; 272(17):11420-5. PubMed ID: 9111052
[TBL] [Abstract][Full Text] [Related]
12. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy.
Pizard A; Blaukat A; Michineau S; Dikic I; Müller-Esterl W; Alhenc-Gelas F; Rajerison RM
Biochemistry; 2001 Dec; 40(51):15743-51. PubMed ID: 11747451
[TBL] [Abstract][Full Text] [Related]
13. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of six novel classes of nonpeptide antagonists of the bradykinin B2 receptor.
Artis DR; Brotherton-Pleiss C; Pease JH; Lin CJ; Ferla SW; Newman SR; Bhakta S; Ostrelich H; Jarnagin K
Bioorg Med Chem Lett; 2000 Nov; 10(21):2421-5. PubMed ID: 11078192
[TBL] [Abstract][Full Text] [Related]
15. FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.
Rizzi A; Gobeil F; Calò G; Inamura N; Regoli D
Hypertension; 1997 Apr; 29(4):951-6. PubMed ID: 9095082
[TBL] [Abstract][Full Text] [Related]
16. Cloning, sequencing and functional expression of a guinea pig lung bradykinin B2 receptor.
Farmer SG; Powell SJ; Wilkins DE; Graham A
Eur J Pharmacol; 1998 Apr; 346(2-3):291-8. PubMed ID: 9652372
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
Robert C; Pruneau D; Paquet JL
Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.
Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Nakahara K; Kojo H; Oku T; Notsu Y
Mol Pharmacol; 1997 Jul; 52(1):16-20. PubMed ID: 9224807
[TBL] [Abstract][Full Text] [Related]
19. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
